Intas acquisition loan rakes in $670m of commitments
A dual currency financing to back Indian company Intas Pharmaceuticals’ acquisition of a portfolio of assets in the UK and Ireland has netted $650m-$670m of commitments.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: